The JNK signaling pathway against titanium-particle-induced osteoclastogenesis and bone resorption in vivo
Z.-G. Liu, J.-B. Zhao, C. Zhang, A. Yuan, W.-P. Wang, Y.-L. Xie, D.-S. Chen, Y. Liu School of Clinical Medicine, Guangxi Medical University, Nanning, China. chendesheng@nxmu.edu.cn
OBJECTIVE: The c-Jun N-terminal kinases (JNK) signaling pathway may be involved in the regulation of osteoclast development. The purpose of this investigation was to investigate whether SB600125, a JNK inhibitor, could attenuate titanium-particle-induced inflammatory osteolysis in vivo.
MATERIALS AND METHODS: A total of 45 mice were randomly divided into a Sham group, a Titanium group, and a Titanium + JNK inhibitor group, 15 mice per group. After establishing an air pouch bone graft model, we injected phosphate-buffered saline (PBS), titanium particles, or titanium particles + JNK inhibitor into the air pouch of the three groups. The pouch membranes containing bone implants were taken for morphological and molecular analysis 14 days after the mice were sacrificed.
RESULTS: General morphological structure observation results, Hematoxylin and Eosin (H&E)-Stained Sections, anti-tartaric acid phosphatase (TRAP) staining, and the transmission electron microscope showed that SB600125, by inhibiting the expression of JNK, attenuated titanium particle-induced inflammatory osteolysis (p<0.05). Immunohistochemical appearance results and reverse transcription-polymerase chain reaction (RT-PCR) results showed SB600125 reduced expression of IL-6, and TNF-α in osteolytic sites stimulated with wear debris (p<0.05). The Western blot results showed the expression of the p-JNK protein in the titanium particle + SB600125 group was significantly reduced compared to the titanium particle stimulation group (p<0.05).
CONCLUSIONS: Interfering with the JNK signaling pathway may be beneficial in reducing osteolysis, providing a therapeutic target for preventing and treating aseptic loosening caused by debris-induced inflammatory osteolysis.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
Z.-G. Liu, J.-B. Zhao, C. Zhang, A. Yuan, W.-P. Wang, Y.-L. Xie, D.-S. Chen, Y. Liu
The JNK signaling pathway against titanium-particle-induced osteoclastogenesis and bone resorption in vivo
Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 21
Pages: 10301-10312
DOI: 10.26355/eurrev_202311_34305